Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

被引：36
|
作者：
Lee, Sung Won [1 ,2 ]
Choi, Jonggi [3 ]
Kim, Seung Up [4 ,5 ]
Lim, Young-Suk [3 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ, Liver Res Ctr, Seoul, South Korea
[3] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[4] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2021年 / 27卷 / 03期
关键词：
Entecavir; Tenofovir; Hepatitis B; Carcinoma; Hepatocellular; Efficacy; Outcome; DISOPROXIL FUMARATE; RISK; CIRRHOSIS;
D O I：
10.3350/cmh.2021.0179
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.
引用
收藏
页码：402 / 412
页数：11
相关论文
共 50 条
  • [31] Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
    Cheung, Ka Shing
    Mak, Lung Yi
    Liu, Sze Hang
    Cheng, Ho Ming
    Seto, Wai Kay
    Yuen, Man Fung
    Lai, Ching Lung
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 (10) : e00236
  • [32] Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
    Dave, Shravan
    Park, Sooyoung
    Murad, M. Hassan
    Barnard, Abbey
    Prokop, Larry
    Adams, Leon A.
    Singh, Siddharth
    Loomba, Rohit
    HEPATOLOGY, 2021, 73 (01) : 68 - 78
  • [33] Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-J.
    Lee, Teng-Yu
    Huang, Yen-Tsung
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Wu, Chun-Ying
    El-Serag, Hashem B.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 543 - 551
  • [34] Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis
    Lee, Hyo-Young
    Oh, Hyunwoo
    Park, Chan-Hyuk
    Yeo, Yee-Hui
    Nguyen, Mindie H.
    Jun, Dae-Won
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (23) : 2961 - 2972
  • [35] Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective study
    Chen, Chien-Hung
    Chen, Chi-Yi
    Wang, Jing-Houng
    Lai, Hsueh-Chou
    Hung, Chao-Hung
    Lu, Sheng-Nan
    Peng, Cheng-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3882 - +
  • [36] Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
    Liu, Hui
    Han, Cheng-Long
    Tian, Bao-Wen
    Ding, Zi-Niu
    Yang, Ya-Fei
    Ma, Yun-Long
    Yang, Chun-Cheng
    Meng, Guang-Xiao
    Xue, Jun-Shuai
    Wang, Dong-Xu
    Dong, Zhao-Ru
    Chen, Zhi-Qiang
    Hong, Jian-Guo
    Li, Tao
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (06) : 623 - 633
  • [37] Systematic Review with Meta-Analysis: Comparison of the Risk of Hepatocellular Carcinoma in Antiviral-Naive Chronic Hepatitis B Patients Treated with Entecavir versus Tenofovir: The Devil in the Detail
    Oh, Hyunwoo
    Lee, Hyo Young
    Kim, Jihye
    Kim, Yoon Jun
    CANCERS, 2022, 14 (11)
  • [38] Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
    Sinakos, Emmanouil
    Kachru, Nandita
    Tsoulas, Christos
    Jeyakumar, Sushanth
    Smith, Nathaniel J.
    Yehoshua, Alon
    Cholongitas, Evangelos
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (04) : e230090
  • [39] Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kim, Kyunga
    Kim, Hyeseung
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    GUT AND LIVER, 2016, 10 (06) : 939 - 947
  • [40] Tenofovir is Superior to Entecavir in Patients with Treatment-naive Hepatitis B e-Antigen-Positive Chronic Hepatitis B
    Behera, Manas K.
    Pati, Girish K.
    Narayan, Jimmy
    Mishra, Debakanta
    Meher, Lalit K.
    Singh, Ayaskant
    Uthansingh, Kanishka
    Sahu, Manoj K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (01) : 37 - 44
12345